Skip to main content
Market intelligence
RAINHealthcare

Rain Oncology Inc insider activity

In the last 90 days, 1 corporate insider purchased $104,225 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
1
90-day purchase value
$104,225
Corporate buyers
1
Latest transaction
Aug 19, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 19, 2026Randy SeidlChief Executive OfficerOpen Market Purchase110,000$0.95$104,225
May 22, 2025Randy SeidlChief Executive OfficerOpen Market Purchase42,514$2.37$100,949